Also, as of May 16, 2024, Jonathan W.R. Ross did not stand for reelection at the Company’s 2024 annual meeting of shareholders (the “Annual Meeting”) and therefore retired from service as a member of the Board of Directors of the Company and the Bank.
Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
Mr. Mintzberg will succeed Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
Mr. Mintzberg will succeed Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
Departed
Michael Sonnenshein
Chief Executive Officer and principal executive officer
Mr. Mintzberg will succeed Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
Mr. Mintzberg will succeed Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
Michael Sonnenshein, the current Chief Executive Officer of Grayscale and the principal executive officer of the Company, who has decided to step down from his position, effective immediately.
Departed
Peter B. Delaney
Director
PHX MINERALS INC.
Effective
2024-05-16
Filed
May 20, 2024, 7:59 PM ET
Peter B. Delaney informed the Company’s Board of Directors (the “Board”) that he had decided to retire from the Board effective as of the 2024 Annual Meeting of Stockholders of the Company, which was held on May 16, 2024 (the “2024 Annual Meeting”).
As previously disclosed, Kimberly S. Maready, who currently serves as Vice President – Accounting and Finance of the Company and is designated as the principal accounting officer of the Company, notified the Company that she will be retiring from the Company on the Effective Date.
Departed
Stephen E. Croskrey
Chief Executive Officer
Danimer Scientific, Inc.
Filed
May 20, 2024, 7:59 PM ET
On May 20, 2024, Stephen E. Croskrey informed Danimer Scientific, Inc. (the “Company”) of his intention to retire from employment with the Company on or before December 31, 2024.
Departed
Stephen E. Croskrey
Chairman of the Board
Danimer Scientific, Inc.
Effective
2024-05-20
Successor
Richard Hendrix
Filed
May 20, 2024, 7:59 PM ET
On May 20, 2024, Stephen E. Croskrey informed Danimer Scientific, Inc. (the “Company”) of his intention to retire from employment with the Company on or before December 31, 2024.
On May 16, 2024, Joseph Watters and William H. McGill, Jr. informed the Board of Directors (the “Board”) of MarineMax, Inc. (the “Company”) that each intends to retire as a director of the Company, effective June 30, 2024.
On May 16, 2024, Joseph Watters and William H. McGill, Jr. informed the Board of Directors (the “Board”) of MarineMax, Inc. (the “Company”) that each intends to retire as a director of the Company, effective June 30, 2024.
Jennifer Fulk and the Company have mutually agreed that Ms. Fulk will step down from her position as Chief Financial Officer, effective as of May 20, 2024.
On May 20, 2024, QCR Holdings, Inc. (the “Company”) announced that effective January 3, 2025, John H. Anderson will retire (the “Retirement”) from his roles as Chief Deposit Officer for the Company and as Chief Executive Officer for the Company’s wholly-owned bank subsidiary, Quad City Bank and Trust Company (“QCBT”).
Departed
James N. Topper
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Christopher Peetz
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Jörn Drappa
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Peter Thompson
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Robert Conway
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Natasha Hernday
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Mitchell H. Gold
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Min Cui
Director
ALPINE IMMUNE SCIENCES, INC.
Effective
2024-05-20
Successor
Charles Wagner
Filed
May 20, 2024, 7:59 PM ET
As of the Effective Time, Mitchell H. Gold, Robert Conway, Min Cui, Natasha Hernday, Christopher Peetz, Peter Thompson, James N. Topper and Jörn Drappa each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
effective May 15, 2024, director Donald L. Nickles retired from the Board in accordance with the terms of Valero Energy Corporation’s (“Valero”) director retirement policy.
Departed
Julie H. Boushka
Senior Vice President and Chief Accounting Officer
On May 15, 2024, Julie H. Boushka gave notice to Targa Resources Corp. (the “Company”) of her intent to retire from her position as Senior Vice President and Chief Accounting Officer of the Company, effective March 1, 2025.
Departed
Amy B. Schwetz
Member of the Board of Directors and Chair of the Audit Committee
On May 17, 2024, Amy B. Schwetz, a member of the Board of Directors (the “Board”) of Dril-Quip, Inc. (“Dril-Quip”) and chair of the Audit Committee thereof, notified Dril-Quip of her intention to resign, effective immediately, from the Board.
On May 18, 2024, Kenneth S. Wilson ceased to serve as Chief Executive Officer and Director of Jabil Inc. ("Jabil") following the completion of the previously announced internal investigation related to corporate policies.
James M. Jenkins notified the board of directors of Transcat, Inc. (the “Company”) of his intention to resign as Chief Legal and Corporate Development Officer of the Company effective as of June 1, 2024.
On May 17, 2024 (the “Effective Date”), Leonard Sokolow notified the Board of Directors (the “Board”) of the Company that he will resign as a member of the Board and its committees, effective as of the Effective Date
On May 15, 2024, Chief Financial Officer Mr. Daniel Machock’s service to Aspire and the Company ended
Departed
Mohammed Javade Chaudhri
Class I Director
Alternus Clean Energy, Inc.
Effective
2024-05-15
Filed
May 20, 2024, 7:59 PM ET
On May 15, 2024, Mohammed Javade Chaudhri, a Class I director of Altenrus Clean Energy, Inc. (the “Company”), notified the Company that they will resign from the Company’s Board of Directors (the “Board”) effective immediately.
On May 15, 2024, John Penver, the Chief Financial Officer of TSS, Inc. (the “Company”) tendered his resignation as the Company’s Chief Financial Officer, effective June 15, 2024.
Dr. Tanner’s employment with the Company will terminate effective May 31, 2024, and, effective June 1, 2024, Dr. Tanner will begin service as a consultant to the Company.
Departed
A. Alexander Taylor, II
Director
DELTA APPAREL, INC
Effective
2024-05-14
Filed
May 20, 2024, 7:59 PM ET
On May 14, 2024, A. Alexander Taylor, II resigned from service on the Delta Apparel, Inc. Board of Directors (“Board”) and all subcommittees of the Board effective May 14, 2024.
On May 13, 2024, Starlette B. Johnson, Interim Chief Executive Officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”) and member of the Company’s Board of Directors (the “Board”), resigned from her position as Interim Chief Executive Officer effective immediately.
On May 17, 2024, Patrick Kolek provided notice to the Board of Directors (the “Board”) of Skillsoft Corp. (the “Company”) of his decision not to stand for re-election to the Board.
On May 20, 2024, Michael Preston notified AdvanSix Inc. (the “Company”) of his intention to retire from his position as Chief Financial Officer during the 2024 fiscal year.
On May 20, 2024, Jodi Hanson Bond and James Fagan notified AFC Gamma, Inc. (the “Company”) of their respective decisions to resign as directors of the Company, effective upon the completion of the Company’s spin-off of its separate commercial real estate portfolio into an independent, publicly-traded REIT, Sunrise Realty Trust, Inc. (“SUNS”).
On May 20, 2024, Jodi Hanson Bond and James Fagan notified AFC Gamma, Inc. (the “Company”) of their respective decisions to resign as directors of the Company, effective upon the completion of the Company’s spin-off of its separate commercial real estate portfolio into an independent, publicly-traded REIT, Sunrise Realty Trust, Inc. (“SUNS”).
Departed
Patrick Schumacher
Vice President and President, Chlor Alkali Products and Vinyls
On May 13, 2024, Olin Corporation (“Olin”) and Mr. Patrick Schumacher, Vice President and President, Chlor Alkali Products and Vinyls, mutually agreed that Mr. Schumacher's employment with Olin will cease effective September 1, 2024.
On May 15, 2024, Sandford D. Smith notified Cytokinetics, Incorporated (the “Company”) of his resignation from the Board of Directors of the Company (the “Board of Directors”), with such resignation effective immediately before the 2024 annual meeting of stockholders of the Company held on May 15, 2024 (the “Annual Meeting”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.